Could the use of a new novel bipolar radiofrequency device (Aerin) improve nasal valve collapse? A systematic review and meta-analysis.
NOSE score
Nasal valve collapse
Office-based procedure
Radiofrequency treatment
Vivaer
Journal
Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale
ISSN: 1916-0216
Titre abrégé: J Otolaryngol Head Neck Surg
Pays: England
ID NLM: 101479544
Informations de publication
Date de publication:
22 Jun 2023
22 Jun 2023
Historique:
received:
05
07
2022
accepted:
22
04
2023
medline:
26
6
2023
pubmed:
23
6
2023
entrez:
22
6
2023
Statut:
epublish
Résumé
Surgical treatment for nasal obstruction caused by nasal valve collapse requires a significant recovery period and risks of complications, while nasal dilators are uncomfortable. Recently, radiofrequency treatment of lateral walls has been used under local anesthesia as an office base surgery. This work aims to assess the efficacy of a new radiofrequency device, the Vivaer™ System (Aerin Medical, Sunnyvale, CA), to treat nasal obstruction through a systematic review and meta-analysis. Two researchers independently reviewed the literature up to December 2021. Studies on patients seeking treatment for nasal obstruction due to nasal valve collapse were included in the analysis. Four studies (218 patients) met the inclusion criteria and treated the nasal valve regions bilaterally with the Aerin Medical Vivaer™ System. After the treatment, the NOSE score was reduced at three months postoperatively. Minor adverse events were reported in the included studies, and two showed no complications. None of the studies reported changes in the external appearance of the nose. The radiofrequency treatment using the Vivaer device can be useful for treating nasal valve collapse, improving significantly subjective breathing symptom scores. Further studies on a large scale are needed to confirm these results.
Sections du résumé
BACKGROUND
BACKGROUND
Surgical treatment for nasal obstruction caused by nasal valve collapse requires a significant recovery period and risks of complications, while nasal dilators are uncomfortable. Recently, radiofrequency treatment of lateral walls has been used under local anesthesia as an office base surgery. This work aims to assess the efficacy of a new radiofrequency device, the Vivaer™ System (Aerin Medical, Sunnyvale, CA), to treat nasal obstruction through a systematic review and meta-analysis.
METHODS
METHODS
Two researchers independently reviewed the literature up to December 2021. Studies on patients seeking treatment for nasal obstruction due to nasal valve collapse were included in the analysis.
RESULTS
RESULTS
Four studies (218 patients) met the inclusion criteria and treated the nasal valve regions bilaterally with the Aerin Medical Vivaer™ System. After the treatment, the NOSE score was reduced at three months postoperatively. Minor adverse events were reported in the included studies, and two showed no complications. None of the studies reported changes in the external appearance of the nose.
CONCLUSION
CONCLUSIONS
The radiofrequency treatment using the Vivaer device can be useful for treating nasal valve collapse, improving significantly subjective breathing symptom scores. Further studies on a large scale are needed to confirm these results.
Identifiants
pubmed: 37349806
doi: 10.1186/s40463-023-00644-7
pii: 10.1186/s40463-023-00644-7
pmc: PMC10286448
doi:
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
42Informations de copyright
© 2023. The Author(s).
Références
Facial Plast Surg Clin North Am. 2017 May;25(2):179-194
pubmed: 28340649
Otolaryngol Head Neck Surg. 2008 Jul;139(1):10-20
pubmed: 18585555
Int Forum Allergy Rhinol. 2020 Jun;10(6):719-725
pubmed: 32282129
Otolaryngol Clin North Am. 2018 Oct;51(5):929-944
pubmed: 30017094
Int Forum Allergy Rhinol. 2021 Dec;11(12):1676-1684
pubmed: 34240571
Eur Arch Otorhinolaryngol. 2019 Apr;276(4):1039-1047
pubmed: 30607559
Am J Rhinol Allergy. 2013 May-Jun;27(3):234-6
pubmed: 23710960
Acta Otorhinolaryngol Ital. 2016 Jun;36(3):199-205
pubmed: 27214831
Am J Rhinol. 2004 May-Jun;18(3):143-50
pubmed: 15283487
Arch Facial Plast Surg. 2003 Jan-Feb;5(1):46-52
pubmed: 12533139
JAMA Facial Plast Surg. 2014 May-Jun;16(3):219-25; quiz 232
pubmed: 24604253
Int Forum Allergy Rhinol. 2021 Apr;11(4):755-765
pubmed: 32810380
Facial Plast Surg Clin North Am. 2016 Aug;24(3):219-34
pubmed: 27400837
Laryngoscope. 2021 Jun;131(6):E1760-E1769
pubmed: 33140876
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Facial Plast Surg Clin North Am. 2019 Aug;27(3):367-371
pubmed: 31280850
Facial Plast Surg. 2022 Feb;38(1):57-65
pubmed: 34905801
Otolaryngol Head Neck Surg. 2017 Aug;157(2):325-330
pubmed: 28418779
J Oral Maxillofac Surg. 2021 Oct;79(10):2134-2142
pubmed: 34214476
Am J Rhinol. 2003 Mar-Apr;17(2):107-10
pubmed: 12751706
Laryngoscope Investig Otolaryngol. 2019 Feb 04;4(2):211-217
pubmed: 31024989
Lasers Surg Med. 2012 Sep;44(7):572-9
pubmed: 22886463
Aesthetic Plast Surg. 2021 Jun;45(3):1127-1136
pubmed: 33399950